“…Data from early studies exploring GBM permeability provide compelling evidence in support this concept, demonstrating that anionic charge does establish an electrostatic barrier that hinders/constrains the flux of polycationic solutes across the GBM (Chang et al, 1975; Rennke et al, 1975; Brenner et al, 1977, 1978; Deen et al, 1977; Rennke & Venkatachalam, 1977). In extrapolating that conceptual function to explain pathophysiologic events seen in disease, it was logical to surmise that the loss of GBM anionic charge would develop in diseases/disease models in which proteinuria occurs (Ala-Houhala & Pasternack, 1987; Okada et al, 1989; Wada et al, 1990; Gambaro et al, 1992; Morano et al, 1993; Fox et al, 1994; Morano et al, 1994; Goode et al, 1995; van den Born et al, 1995; Raats et al, 2000; Sakagami et al, 2004; Takahashi et al, 2006). Although the GBM has both size and charge selectivity, the molecular weight cutoff for the barrier is still a highly contested issue in the field of renal function (Singh et al, 2011).…”